Major medical and technology firm Convatec, has revealed its strategic plans to move its Research and Development operations to Bruntwood ScTech’s CityLabs 4.0 as part of over £742 million of investment in the UK and US over the next decade.
The FTSE 100 company will pour the investment into a new ‘flagship’ Manchester hub in 2027.
The site is set to be one of the largest in its global network of technology and innovation centres, according to the group. The new site will be the location for vital research into advanced wound care, ostomy care, continence care and infusion care, placing the company at the forefront of medical technology development.
Interim chief executive Jonny Mason at Convatec said: “Our plans to invest more than $1bn – anchored by major expansion plans in both the United States and the United Kingdom – demonstrates our unwavering commitment to advancing healthcare innovation for people living with chronic conditions around the world”.
Many of Convatec’s current employees, based at the existing site in Deeside, North Wales will be relocating to Manchester as part of the new research hub. The new Manchester hub is estimated to have capacity for up to 250 employees, and is 50% larger than the current facility.
